Impressive survival data with semimetronomic oral chemotherapy with old agents in heavily treated metastatic breast cancer patients

被引：0
|
作者：
Mutlu, H. [1 ,2 ]
Bozcuk, H. [1 ,2 ]
Ozdogan, M. [1 ,2 ]
Artac, M. [1 ,2 ]
Coskun, H. S. [1 ,2 ]
Kargi, A. [1 ,2 ]
Uysal, M. [1 ,2 ]
Savas, B. [1 ,2 ]
机构：
[1] Akdeniz Univ, Sch Med, TR-07058 Antalya, Turkey
[2] Selcuk Univ, Meram Sch Med, Konya, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1082
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer
    Bartsch, Rupert
    Wenzel, Catharina
    Gampenrieder, Simon P.
    Pluschnig, Ursula
    Altorjai, Gabriela
    Rudas, Margaretha
    Mader, Robert M.
    Dubsky, Peter
    Rottenfusser, Andrea
    Gnant, Michael
    Zielinski, Christoph C.
    Steger, Guenther G.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 903 - 910
  • [42] Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer
    Rupert Bartsch
    Catharina Wenzel
    Simon P. Gampenrieder
    Ursula Pluschnig
    Gabriela Altorjai
    Margaretha Rudas
    Robert M. Mader
    Peter Dubsky
    Andrea Rottenfusser
    Michael Gnant
    Christoph C. Zielinski
    Guenther G. Steger
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 903 - 910
  • [43] Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients
    Tokudome, Nahomi
    Ito, Yoshinori
    Takahashi, Shunji
    Kobayashi, Kokoro
    Taira, Shinichiro
    Tsutsumi, Chizuko
    Oto, Masafumi
    Oba, Masaru
    Inoue, Kenichi
    Kuwayama, Akiko
    Masumura, Kyoko
    Nakayama, Yoshie
    Watanabe, Chie
    Hatake, Kiyohiko
    BREAST CANCER, 2011, 18 (03) : 195 - 202
  • [44] Prognostic and predictive factors of eribulin in patients with heavily pre-treated metastatic breast cancer
    Chen, Pei-Hsin
    Yeh, Dah-Cherng
    Tung, Heng-Hsin
    Lin, Chin-Yao
    MEDICINE, 2021, 100 (47)
  • [45] Oral Chemotherapy in Elderly Women with Metastatic Breast Cancer
    Molina-Garrido, M. J.
    Mora-Rufete, A.
    Guillen-Ponce, C.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (05) : 665 - 672
  • [46] Review of utilisation of Oral Chemotherapy Clinic (OCC) to improve quality of care for metastatic breast cancer patients receiving oral anti-cancer agents
    Sinha, Priyadarshini
    Murphy, Caitlin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 196 - 197
  • [47] Lack of survival benefit in metastatic breast cancer with newer chemotherapy agents: The City of Hope experience
    Pal, S. K.
    Gupta, R.
    Somlo, G.
    Hurria, A.
    Chung, C. T.
    Luu, T. H.
    Bernstein, L.
    Mortimer, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] FAILURE OF CHEMOTHERAPY TO PROLONG SURVIVAL IN A GROUP OF PATIENTS WITH METASTATIC BREAST-CANCER
    POWLES, TJ
    SMITH, IE
    FORD, HT
    COOMBES, RC
    JONES, JM
    GAZET, JC
    LANCET, 1980, 1 (8168): : 580 - 582
  • [49] IMPACT OF CHEMOTHERAPY ON SURVIVAL IN METASTATIC BREAST-CANCER
    PATERSON, AHG
    LEES, AW
    HANSON, J
    SZAFRAN, O
    CORNISH, F
    LANCET, 1980, 2 (8189): : 312 - 312
  • [50] Improving Adherence With Oral Antiemetic Agents in Patients With Breast Cancer Receiving Chemotherapy
    Hendricks, Carolyn B.
    JOURNAL OF ONCOLOGY PRACTICE, 2015, 11 (03) : 216 - +
12345